Pramana, Inc., an AI-enabled health tech company modernizing the pathology sector, and ARUP Laboratories, the largest nonprofit clinical and academic reference laboratory in the United States, announced a collaboration to digitize pathology slides and develop AI-powered algorithms to improve the assessment of bone marrow biopsies and address other key diagnostic challenges in hematopathology. The partnership combines ARUP’s hematopathology expertise with Pramana’s cutting-edge SpectralHT autonomous whole-slide imaging scanners to advance diagnostic precision and efficiency.
Health Technology Insights: Emids Appoints Abhishek Shankar as CEO to Drive Next Growth Phase
“Hematopathology involves highly complex and difficult-to-scan specimens, where traditional methods often fall short in delivering consistent and reproducible results,” said David Ng, MD, medical director of Hematologic Flow Cytometry and Applied Artificial Intelligence at ARUP Laboratories. “By combining our deep clinical expertise with Pramana’s large-scale digitization and AI-driven analysis, we have the ability to develop and clinically validate new AI algorithms that will improve diagnostic accuracy and workflow efficiency. Additionally, this collaboration lays the foundation for the broad distribution of these AI tools, ensuring greater accessibility and impact across the pathology community.”
The AI model development process will be led by ARUP, drawing on its expert hematopathologists and annotation tools to train, refine, and validate the algorithms using real-world clinical cases and pathology slides obtained for this purpose. These algorithms will be designed and tested to run efficiently on Pramana’s SpectralHT scanners, demonstrating the viability of in-line edge computing for real-time AI-powered diagnostics. ARUP and Pramana will explore commercialization strategies to enable the seamless deployment and distribution of advanced diagnostic algorithms per regulatory standards, which will run efficiently on scanners and drive broader industry adoption in clinical diagnostics.
Health Technology Insights: MedaSystems Secures Seed Funding to Enhance Its AI Platform for Expanded Research Access
“This collaboration with ARUP Laboratories showcases how AI-driven pathology can redefine industry standards, making diagnostics more scalable, efficient, and interoperable,” said Prasanth Perugupalli, chief product officer at Pramana. “By leveraging edge computing, we’re accelerating the adoption of advanced diagnostic algorithms, including those for complex hematopathology cases. This approach enhances precision, removes scalability barriers, and seamlessly integrates AI-driven insights into lab workflows.”
Pramana’s SpectralHT scanners feature in-line Edge AI computing, allowing real-time quality control and automated image processing. This streamlined workflow reduces the burden on lab personnel while ensuring high-quality data output. The SpectralHT scanners’ volumetric imaging capabilities improve image quality and detail while enhancing scanning efficiency, even for the most challenging diagnostic slides, such as microbiology, hematopathology, parasitology, and cytology.
The ongoing partnership between ARUP Laboratories and Pramana underscores a broader commitment to digitization and AI-driven pathology advancements, signaling the potential for deeper integration and expanded initiatives, including clinical applications.
Health Technology Insights: Radicle Science Unveils Journey: A New Innovation From the Healthtech Pioneer
To participate in our interviews, please write to our HealthTech Media Room at news@intentamplify.com
Source – businesswire
